MEDtalks webinar – Does insulin still have a place in the management of hyperglycaemia in T2D?
Insulin, our first pharmacotherapeutic agent and King, is almost a centenarian – but is it time for the old King to abdicate? Are GLP1-RAs the rightful heirs to the injectable kingdom or simply adolescent upstarts needing to earn their right to the throne? Join us for this lively and entertaining MEDTalk presented by three prominent…